Diseases [C] » Musculoskeletal Diseases [C05] » Rheumatic Diseases
Diseases [C] » Skin and Connective Tissue Diseases [C17] » Connective Tissue Diseases » Rheumatic Diseases
Description
Disorders of connective tissue, especially the joints and related structures, characterized by inflammation, degeneration, or metabolic derangement. MeSH
Hierarchy View
Subtype Terms (8)
Arthritis, Juvenile
87 drugs (66 approved, 21 experimental)
Arthritis, Rheumatoid
583 drugs (234 approved, 349 experimental)
Fibromyalgia
133 drugs (83 approved, 50 experimental)
Gout
105 drugs (61 approved, 44 experimental)
Hyperostosis, Sternocostoclavicular
Osteoarthritis
325 drugs (146 approved, 179 experimental)
Polymyalgia Rheumatica
22 drugs (19 approved, 3 experimental)
Rheumatic Fever
11 drugs (5 approved, 6 experimental)
Approved Indicated Drugs (4)
Phase 3 Indicated Drugs (3)
Phase 2 Indicated Drugs (3)
Phase 1 Indicated Drugs (4)
Other Experimental Indicated Drugs (5)
Organization Involved with Phase 4 Indications (11)
Organization Involved with Phase 3 Indications (14)
Organization Involved with Phase 2 Indications (18)
Organization Involved with Phase 1 Indications (7)
Organization Involved with Other Experimental Indications (5)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
